Lasting Damage After Monolateral Acute Primary Angle Closure

This article originally appeared here.
Share this content:
Lasting Damage After Monolateral Acute Primary Angle Closure
Lasting Damage After Monolateral Acute Primary Angle Closure

MONDAY, July 24, 2017 (HealthDay News) -- Significantly greater structural and functional damage occurs in eyes with monolateral acute primary angle closure (APAC) compared with fellow eyes, and more than half of fellow eyes develop chronic angle closure glaucoma (CACG), according to research published online July 19 in Clinical & Experimental Ophthalmology.

In an effort to report the morphological and functional outcomes for CACG eyes following a monolateral APAC attack, Antonio Maria Fea, M.D., Ph.D., from the University of Turin in Italy, and colleagues conducted an observational retrospective case series involving 57 patients (114 eyes) who underwent long-term follow-up analysis. Patients underwent ophthalmic assessment at more than five years following the attack (mean follow-up, 5.86 ± 1.19 years).

The researchers found that, compared with fellow eyes, APAC eyes had significantly greater damage in structural and functional terms (both P < 0.001). In APAC and fellow eyes, the mean intraocular pressure was 13.44 ± 2.78 and 13.89 ± 2.60 mm Hg, respectively (P = 0.11). Even if prophylactic iridotomy was performed promptly, 53 percent of fellow eyes developed CACG.

"Our study prompts ophthalmologists to closely follow up patients after an APAC attack to prevent potential glaucoma damage in both APAC and fellow eye," the authors write

Abstract
Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »


Sign up for myCME e-newsletters


Drug Lookup

Browse drugs by: BrandGenericDisease

Trending Activities

All Professions

More in Home

Zika Does Not Appear to Last in Semen As Long As Thought

Zika Does Not Appear to Last in Semen ...

More research is needed to better inform public health recommendations

Radioiodine Therapy for Thyroid Cancer Doesn't Up Stroke Risk

Radioiodine Therapy for Thyroid Cancer Doesn't Up Stroke ...

I-131 therapy group showed no significantly higher risk of ischemic or hemorrhagic stroke

Higher Odds of Infection With Reduced Kidney Function

Higher Odds of Infection With Reduced Kidney Function

Study finds excess community-acquired infections incidence in individuals with mild to severe CKD

is free, fast, and customized just for you!

Already a member?

Sign In Now »